title: Preclinical safety assessment considerations in vaccine development.
authors.affiliation: Department of Pathobiology and Toxicology, Genentech, Inc., South San Francisco, California 94080, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Bussiere
authors.forename: G C
authors.initials: GC
authors.lastname: McCormick
authors.forename: J D
authors.initials: JD
authors.lastname: Green
mesh_terms: D000818:Animals; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D014612:Vaccines / Q000009:adverse effects*; D014613:Vaccines, Attenuated / Q000009:adverse effects; D015164:Vaccines, Inactivated / Q000009:adverse effects; D014614:Vaccines, Synthetic / Q000009:adverse effects
chemical_list: D014612:Vaccines; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic